SkyRiver Ventures — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Holobiome, Inc.holobiome.org in 𝕏Oct 2024

Holobiome discovers and develops therapies derived from the human gut microbiome, working to translate microbiome science into probiotics and targeted treatments for whole-body health.

AI & Machine LearningBiotechHealthtechLongevityBoston, US

Philip Strandwitz(Co-founder & Director, Chief Executive Officer)inKim Lewis(Co-founder, Director)Mike La Fleur(President, Co-founder, Director)Michael LaFleur(Executive Officer)

BoardJoan LaRovere(Director)inIain Chessell(Director)

Co-investorsAble Partners Bantam Group Healthtech Capital iSelect Fund Pace Ventures Service Provider Capital +3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.